Navigation Links
Accuray's General Counsel Wins Best Bay Area Corporate Counsel Award
Date:2/25/2011

and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 100,000 patients worldwide and currently more than 222 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit www.accuray.com

Safe Harbor Statement

The foregoing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release, including statements relating to management experience and market acceptance are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events. You should not put undue reliance on any forward-looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: range of treatment options, clinical applications, clinical results and market acceptance of products and other risks detailed from time to time under the heading "Risk Factors" in our report on Form 10-K for our 2010 fiscal year, our form 10-Q filed on January 27, 2011 and our other filings with the Securities and Exchange Commission. The Company's actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors. We assume no obliga
'/>"/>

SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pioneer® Surgical Technology, Inc. Enters the Biologics Extremities, Trauma, and General Orthopaedics Market with Legato™ Bone Void Filler
2. Florida Pain Clinic Organizations Applaud FL Senate President Haridopolos and Attorney General Bondi
3. Hologic Appoints Mark D. Myslinski as Senior Vice President and General Manager of Diagnostics
4. Veridex, LLC Announces Collaboration to Develop Next-Generation Circulating Tumor Cell (CTC) Technology with Massachusetts General Hospital
5. Mindray Medical Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting
6. Med Time Technology, Inc. Teams up with Give A Smile, Inc. to Provide Pill Timer™ Kits and Toys to Children and Parents at the Chris Evert Childrens Hospital of Broward General
7. Distributed by the Export-Import Bank of the United States On Behalf of the Independent Office of Inspector General
8. Auditor General Jack Wagner Says State Could Save Millions by Consolidating Prescription Drug Purchases
9. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting
10. Concord Medical to Hold Annual General Meeting on December 11, 2010
11. Allegheny General Hospital Study Suggests Use of Image Guided Intensity Modulated Radiation Therapy Reduces Risk of Impotency in Men Needing Radiation after Prostate Cancer Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... -- Australian biopharmaceutical company Specialised Therapeutics Australia (STA) is pleased ... combination with gemcitabine, will be reimbursed via the Pharmaceutical ... from 1 November. In ... most common cause of cancer mortality. Pancreatic cancer ... lowest 5-year survival of all common cancers at 5.2%. ...
(Date:10/31/2014)... -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP)( ... the development of oral drug delivery systems, announces ... to discuss the clinical results from its Phase ... oral insulin capsules, to treat type 1 diabetes ... Eastern time. Shareholders and other interested ...
(Date:10/31/2014)... -- Today, Analysts Review released its research ... Bristol-Myers Squibb Co. (NYSE: BMY ), UnitedHealth ... (NYSE: SNY ) and Actavis plc (NYSE: ... publication. To reserve complementary membership, limited openings are available ... Reports ,On October 23, 2014, Celgene Corporation (Celgene) reported ...
Breaking Medicine Technology:Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 3Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 4Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 5Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 6Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 7Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 8Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 2Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 3Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 4Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 5Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 6
... BOZEMAN, Mont., May 01, 2007 /PRNewswire/ -- ... with their influenza virus-like particles (VLPs),induced heterosubtypic ... data were presented by Dr. Joel Haynes, ... Tenth Annual Conference on,Vaccine Research sponsored by ...
... 3, 2007 - Insmed Inc.,(Nasdaq:INSM) today announced positive ... company's drug, IPLEX(TM), in,patients with myotonic muscular dystrophy ... conducted at,the University of Rochester School of Medicine ... doses of IPLEX up to 1,mg/kg/day in six ...
Cached Medicine Technology:LigoCyte Pharmaceuticals Presents Data Showing Heterosubtypic,Protection Against Influenza Challenge With Virus-Like Particle,Immunization 2Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 2Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 3Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 4
(Date:10/31/2014)... kind, Rice University researchers have mapped how information flows ... become metastatic. The research reveals a common pattern in ... and form new tumors. Researchers say the commonality may ... the genetic switches that cancer must flip to form ... two of the main players in cancer metastasis. , ...
(Date:10/31/2014)... Colorado (PRWEB) October 31, 2014 Daily Gossip ... method is actually described as the fastest fat loss program ... in less than a month. , There is no wonder ... loss eBook of all time. The new nutrition and workout ... nutrition and fitness expert. , According to the author ...
(Date:10/31/2014)... 2014 With all the preparations families ... feels they may overlook one critical area – the ... concentration, school performance and even behavior. Typical children’s vision ... identify progressive vision problems, and to address this challenge, ... new initiative: The Awesome Eyes Student Vision Program. ...
(Date:10/31/2014)... may make it hard for you to remember simple things, ... house keys, a small study suggests. Tests on 18 ... called spatial memory -- was impaired when sleep apnea disrupted ... sleep weren,t affected. REM sleep is the deepest level of ... the first time that sleep apnea, an increasingly common medical ...
(Date:10/31/2014)... four older Americans say that either they or a ... according to the latest issue of The Gerontological Society ... ( PP&AR ), which goes on to show that ... to honor patients, end-of-life health care wishes. , This ... and Options ," features 12 articles that present new ...
Breaking Medicine News(10 mins):Health News:Decoding the emergence of metastatic cancer stem cells 2Health News:Decoding the emergence of metastatic cancer stem cells 3Health News:Xtreme Fat Loss Diet Review Reveals How to Transform Your Body in 25 Days 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 3Health News:Sleep Apnea May Steal Some of Your Memory: Study 2Health News:Advance directives can benefit patients, families, and health care system 2
... The nation,s theater owners were asked today by the head of a major Hollywood studio to have healthier snacks at their concession stands in addition to their ... ... ... ...
... eight times more likely to die, study finds , MONDAY, March ... hip are five to eight times more likely to die in ... Belgian researchers has found. , And, while the death rate after ... the break, it never returns to the death rate seen in ...
... of Medicine (BUSM) believe teaching the subject of unhealthy ... training and can be done within existing teaching venues. ... Medical Education , represent a national model for addressing ... use can be serious and chronic and despite its ...
... March 15 The HIMSS Electronic Health ... on two major regulations that implement healthcare IT incentive ... 2009 (ARRA).  One comment addressed the Office of the ... (IFR) on EHR certification criteria and standards.  The other ...
... mouse study suggests , MONDAY, March 15 (HealthDay News) ... a major role in regulating blood pressure, but a ... could also be key, at least after menopause begins. ... to have female chromosomes (XX) and females to have ...
... Mouse study suggests treatment aimed at immune system could work ... cells may one day be a viable treatment for people ... published online in the March 15-19 early edition of the ... its idea from the field of organ transplantation, where multipotent ...
Cached Medicine News:Health News:Movie Theaters Asked to Offer Healthier Snacks at Concession Stands 2Health News:Movie Theaters Asked to Offer Healthier Snacks at Concession Stands 3Health News:Movie Theaters Asked to Offer Healthier Snacks at Concession Stands 4Health News:Movie Theaters Asked to Offer Healthier Snacks at Concession Stands 5Health News:Movie Theaters Asked to Offer Healthier Snacks at Concession Stands 6Health News:Risk of Death Persists After a Hip Fracture 2Health News:Risk of Death Persists After a Hip Fracture 3Health News:Researchers recommend curriculum on unhealthy substance use 2Health News:HIMSS Electronic Health Record Association Responds to Proposed Meaningful Use and Certification Rules 2Health News:HIMSS Electronic Health Record Association Responds to Proposed Meaningful Use and Certification Rules 3Health News:HIMSS Electronic Health Record Association Responds to Proposed Meaningful Use and Certification Rules 4Health News:HIMSS Electronic Health Record Association Responds to Proposed Meaningful Use and Certification Rules 5Health News:Women's Chromosomes May Affect Blood Pressure 2Health News:Stem Cells Might One Day Treat Severe Asthma 2
... the solid, tested XiIIIPlus platform, the ... an unprecedented level of on-demand printing ... as unique features such as XML ... automatic calibration, flexible inlay positioning, multiple ...
... Built on the solid, tested ... offers an unprecedented level of on-demand ... well as unique features such as ... systems, automatic calibration, flexible inlay positioning, ...
... is ideal for applications that ... labels, such as tracking printed ... and identifying small products. The ... ensures text, graphics and bar ...
... The 105SL is the ... S Series™, and its also ... and processing capacity with rugged ... on a proven platform, the ...
Medicine Products: